Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

NCT05250362 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor

Sichuan University